PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

NCT00612651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Gliosarcoma
Glioblastoma
Anaplastic Astrocytoma

Interventions

DRUG: Temodar and SCH 66336

Sponsor

Duke University

Collaborators

[object Object]